Recorded Webinar: Optimization studies: a shared experience

February 01, 2023

From 2023 onwards, the legal obligation to perform yearly optimization studies in radiology comes into force. Dose management systems such as DOSE can greatly help the medical physicist in accessing the data, discovering areas of improvement and tracking the effect of technical changes. These activities are the most essential parts of optimization studies. Vinçotte Controlatom and Qaelum have therefor set up a cooperation to facilitate the interaction between the medical physicist and the hospital data through the DOSE platform. This has already led to promising results, as will be demonstrated during the webinar by a short overview of a completed study performed in this way. Finally, some information will be given on how to set up the system in your hospital to allow a medical physicist to access the data from his or her own workspace.


Jan 26, 2023, 11:00 A.M. - 11:45 A.M. CET


Tom Meylaers, BU Manager at Vinçotte Controlatom
The head of Vinçotte Controlatom and a medical physics expert in his own right, he is both accredit for radiology and for nuclear medicine, with 10+ years of experience in both.


Nelis Van Peteghem, Medical Physics Expert at Vinçotte Controlatom
A medical physics expert accredit for radiology, he has practical experience in performing and completing optimization studies for radiological applications.


Sven Dewilde, Head of Operations at Qaelum
From an engineering and medical physics background, he has been involved on a daily basis with management, support and development of dosimetry and clinical optimization software tools in the past 7 years.


Fill your email address below for the recorded webinar

* indicates required

Please select all the ways you would like to hear from :

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.